Logo image of BEAT

HEARTBEAM INC (BEAT) Stock Fundamental Analysis

NASDAQ:BEAT - US42238H1086 - Common Stock

1.35 USD
+0.08 (+6.3%)
Last: 8/29/2025, 8:07:59 PM
1.35 USD
0 (0%)
After Hours: 8/29/2025, 8:07:59 PM
Fundamental Rating

2

Taking everything into account, BEAT scores 2 out of 10 in our fundamental rating. BEAT was compared to 189 industry peers in the Health Care Equipment & Supplies industry. The financial health of BEAT is average, but there are quite some concerns on its profitability. BEAT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BEAT has reported negative net income.
In the past year BEAT has reported a negative cash flow from operations.
In the past 5 years BEAT always reported negative net income.
In the past 5 years BEAT always reported negative operating cash flow.
BEAT Yearly Net Income VS EBIT VS OCF VS FCFBEAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

The Return On Assets of BEAT (-340.14%) is worse than 98.92% of its industry peers.
The Return On Equity of BEAT (-486.47%) is worse than 85.95% of its industry peers.
Industry RankSector Rank
ROA -340.14%
ROE -486.47%
ROIC N/A
ROA(3y)-333.3%
ROA(5y)-634.31%
ROE(3y)-604.84%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BEAT Yearly ROA, ROE, ROICBEAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BEAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BEAT Yearly Profit, Operating, Gross MarginsBEAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

6

2. Health

2.1 Basic Checks

BEAT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BEAT has been increased compared to 5 years ago.
BEAT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BEAT Yearly Shares OutstandingBEAT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BEAT Yearly Total Debt VS Total AssetsBEAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

BEAT has an Altman-Z score of -11.71. This is a bad value and indicates that BEAT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -11.71, BEAT is doing worse than 82.16% of the companies in the same industry.
There is no outstanding debt for BEAT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -11.71
ROIC/WACCN/A
WACCN/A
BEAT Yearly LT Debt VS Equity VS FCFBEAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

BEAT has a Current Ratio of 2.98. This indicates that BEAT is financially healthy and has no problem in meeting its short term obligations.
BEAT's Current ratio of 2.98 is in line compared to the rest of the industry. BEAT outperforms 58.92% of its industry peers.
BEAT has a Quick Ratio of 2.98. This indicates that BEAT is financially healthy and has no problem in meeting its short term obligations.
BEAT's Quick ratio of 2.98 is fine compared to the rest of the industry. BEAT outperforms 67.57% of its industry peers.
Industry RankSector Rank
Current Ratio 2.98
Quick Ratio 2.98
BEAT Yearly Current Assets VS Current LiabilitesBEAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

1

3. Growth

3.1 Past

BEAT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.37%.
EPS 1Y (TTM)-9.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.05%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, BEAT will show a very strong growth in Earnings Per Share. The EPS will grow by 21.43% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y20.36%
EPS Next 2Y-1.68%
EPS Next 3Y21.43%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BEAT Yearly Revenue VS EstimatesBEAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2023 2025 2026 2027 100M 200M 300M
BEAT Yearly EPS VS EstimatesBEAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BEAT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BEAT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BEAT Price Earnings VS Forward Price EarningsBEAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BEAT Per share dataBEAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as BEAT's earnings are expected to grow with 21.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.68%
EPS Next 3Y21.43%

More info and screens

0

5. Dividend

5.1 Amount

BEAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEARTBEAM INC

NASDAQ:BEAT (8/29/2025, 8:07:59 PM)

After market: 1.35 0 (0%)

1.35

+0.08 (+6.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners9.04%
Inst Owner Change17.65%
Ins Owners11.68%
Ins Owner Change0%
Market Cap46.32M
Analysts80
Price Target4.59 (240%)
Short Float %0.55%
Short Ratio1.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.78%
Min EPS beat(2)-17.65%
Max EPS beat(2)8.09%
EPS beat(4)2
Avg EPS beat(4)-2.22%
Min EPS beat(4)-17.65%
Max EPS beat(4)8.09%
EPS beat(8)3
Avg EPS beat(8)-5.24%
EPS beat(12)4
Avg EPS beat(12)-10.11%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-43.75%
PT rev (3m)-10%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.05%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.87%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 11.08
P/tB 11.08
EV/EBITDA N/A
EPS(TTM)-0.7
EYN/A
EPS(NY)-0.75
Fwd EYN/A
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.45
OCFYN/A
SpS0
BVpS0.12
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -340.14%
ROE -486.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-333.3%
ROA(5y)-634.31%
ROE(3y)-604.84%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2928.57%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.98
Quick Ratio 2.98
Altman-Z -11.71
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.05%
EPS Next Y20.36%
EPS Next 2Y-1.68%
EPS Next 3Y21.43%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-21.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.97%
OCF growth 3YN/A
OCF growth 5YN/A